Holen Sie sich die Stockscreener-App
3.17
2.59%
0.08
Handel nachbörslich:
3.27
0.10
+3.15%
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Xenetic’s Next Test: An ASCO Readout And The Cash Question - Finimize
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - Times Herald
Xenetic Biosciences Grants Equity Award to Interim CEO - The Globe and Mail
Xenetic Biosciences, Inc. Files Form 8-K Announcing Restricted Stock Award Agreement for CEO James Parslow - Minichart
Xenetic Biosciences, Inc. 2025 Annual Report 10-K/A: Executive Compensation, Governance, and Shareholder Information - Minichart
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting - Times Argus
Xenetic Biosciences (NASDAQ: XBIO) updates CEO pay, ownership in 10-K/A - Stock Titan
Xenetic Biosciences (NASDAQ: XBIO) grants CEO/CFO 100,000 restricted shares - Stock Titan
Xenetic Biosciences (XBIO) interim CEO awarded 100,000-share restricted stock grant - Stock Titan
Cancer drug research from Xenetic gets June poster slot at ASCO - Stock Titan
Xenetic Biosciences (XBIO) Stock: Pricing Analysis (Momentum Fading) 2026-04-20Resistance Breakout - Xã Vĩnh Công
Xenetic Biosciences Inc (XBIOW) - Minichart
Xenetic Biosciences (XBIO) Stock Rallies on Launch (Bullish Sentiment) 2026-04-15Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Investment Report: Can Xenetic Biosciences Inc maintain sales growth2026 Valuation Update & Breakout Confirmation Alerts - baoquankhu1.vn
Published on: 2026-04-13 21:59:57 - baoquankhu1.vn
XBIO Q2 2025 Earnings: Xenetic Biosciences Inc. beats EPS views, reports zero revenue - UBND thành phố Hải Phòng
History Review: Is Xenetic Biosciences Inc stock good for income investors2026 Patterns & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Sectors Review: Is Xenetic Biosciences Inc stock undervalued right nowTrade Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn
Loss Report: Is Xenetic Biosciences Inc a potential multi baggerWeekly Risk Report & Risk Controlled Stock Alerts - baoquankhu1.vn
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
XBIO.WS (Xenetic Biosciences) PB Ratio : (As of Apr. 04, 2026) - gurufocus.com
XBIO Q4 Earnings: Beats Estimates by $0.20 - Cổng thông tin điện tử tỉnh Tây Ninh
Highs Report: Is now the right time to enter Xenetic Biosciences Inc2026 PreEarnings & Weekly High Conviction Ideas - baoquankhu1.vn
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Short Interest Update - Defense World
Published on: 2026-03-27 18:33:00 - baoquankhu1.vn
Aug Volume: Is Xenetic Biosciences Inc on track to beat earningsQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn
Analyst Calls: Can Xenetic Biosciences Inc be recession proof2026 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Xenetic (XBIO) Reports Increased Revenue and Advances Clinical D - GuruFocus
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results - Bitget
[8-K] Xenetic Biosciences, Inc. Reports Material Event | XBIO SEC FilingForm 8-K - Stock Titan
Cancer biotech Xenetic grows Takeda royalties to $3M, trims costs - Stock Titan
Xenetic Biosciences: Fourth Quarter Financial Results Overview - Bitget
Xenetic Biosciences 2025 Annual Report: Advancing DNase Immuno-Oncology Technology for Solid Tumors and Strategic Business Developments - Minichart
Xenetic Biosciences: Q4 Earnings Snapshot - KTVB
XBIO: Revenue up 19%, net loss narrows, DNase oncology focus, strategic review underway - TradingView
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
XBIO SEC FilingsXenetic Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Risk On: Can Xenetic Biosciences Inc be recession proofWeekly Profit Summary & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Big Money Moves: Is Xenetic Biosciences Inc stock a value trapJuly 2025 Retail & Community Consensus Stock Picks - baoquankhu1.vn
Published on: 2026-03-07 03:26:22 - baoquankhu1.vn
Xenetic Biosciences adjourns 2025 annual meeting - MSN
Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn
XBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analyst Downgrade: Can Xenetic Biosciences Inc be recession proofQuarterly Investment Review & Safe Capital Allocation Plans - baoquankhu1.vn
XBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results - Montgomery Advertiser
XBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
XBIO Should I Buy - Intellectia AI
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Increase in Short Interest - Defense World
Trading Recap: Is AMKR stock a value trapWeekly Loss Report & Growth Focused Stock Reports - baoquankhu1.vn
Is Xenetic Biosciences Inc stock undervalued right now2025 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
Aug Analyst Calls: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn
Technical Analysis: Is VRMEW affected by consumer sentimentChart Signals & Growth Focused Stock Pick Reports - baoquankhu1.vn
Can Xenetic Biosciences Inc. stock deliver strong Q4 earnings2025 Retail Activity & Safe Swing Trade Setup Alerts - mfd.ru
Investor Mood: Whats the outlook for Xenetic Biosciences Incs sectorWeekly Risk Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Trend Report: Whats the profit margin of Xenetic Biosciences Inc2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn
Aug PreEarnings: Can Xenetic Biosciences Inc maintain sales growthWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn
Support Test: Is National Energy Services Reunited Corp gaining market shareMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
1.77%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):